Use of crf antagonists and related compositions

Details Use of crf antagonists and related compositions Use of crf antagonists and related compositions

C - Chemistry, Metallurgy

07

D

C07D 213/643 (2006.01) A61K 31/41 (2006.01) A61K 31/44 (2006.01) A61K 31/4427 (2006.01) A61K 31/4439 (2006.01) A61K 31/47 (2006.01) A61K 31/495 (2006.01) A61K 31/505 (2006.01) A61K 31/506 (2006.01) A61K 31/519 (2006.01) A61K 31/52 (2006.01) A61K 31/522 (2006.01) A61K 45/06 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2316662

A corticotropin releasing factor (CRF) antagonist is administered to treat a condition selected from the group consisting of: c) disorders that can be treated by altering circadian rhythm; and d) depression, further wherein a second compound for treating depression is administered, the second compound for treating depression having an onset of action that is delayed with respect to that of the CRF antagonist.

Affiliated with

Also associated with

Rating

Use of crf antagonists and related compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of crf antagonists and related compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of crf antagonists and related compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2012963